This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Signpath Pharma, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: James Mcchesney - Innovator in Cardioprotective Lipids
Introduction
James Mcchesney is an inventor based in Etta, MS (US). He has made significant contributions to the field of cardioprotective lipids. Although he currently holds no granted patents, his innovative ideas are reflected in his patent application.
Latest Patent Applications
James Mcchesney's notable patent application is titled "Cardioprotective Lipid and Method of Use." This invention includes a method of reducing or eliminating a cardiotoxic or cardiopathic effect of one or more active agents. The method involves administering to a subject in need thereof an effective amount of one or more lipids that reduce or eliminate the cardiotoxic effect of the active agents. The lipid has a specific formula that is designed to achieve these effects.
Conclusion
James Mcchesney's work in the area of cardioprotective lipids showcases his innovative spirit and dedication to improving health outcomes. His patent application reflects a promising approach to addressing cardiotoxic effects, highlighting his potential as an inventor in this important field.
